Drugs & Targets FDA grants first-ever modified risk orders to eight smokeless tobacco products October 25, 2019Vol.45 No.40
Clinical Roundup Phase III IMbrave150 study demonstrates improved OS + PFS in liver cancer October 25, 2019Vol.45 No.40
Clinical Roundup Novel imaging technology could reduce need for additional surgery after breast cancer resection October 25, 2019Vol.45 No.40
In Brief Michael Birrer named director of UAMS Winthrop P. Rockefeller Cancer Institute October 25, 2019Vol.45 No.40
